---
title: "Jefferies favors low-volatility, high-yield U.S. stocks as AI volatility spikes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292523587.md"
description: "Jefferies analyst Desh Peramunetilleke recommends low-volatility, high-yield U.S. stocks as AI volatility spikes due to concerns over hyperscaler ROI and positioning. He suggests hedging against potential corrections by screening for companies with market caps above $10 billion, low volatility, and dividend or free-cash-flow yields exceeding 3%. Highlighted names include Procter & Gamble, Pfizer, Simon Property Group, and KeyCorp."
datetime: "2026-07-13T19:07:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292523587.md)
  - [en](https://longbridge.com/en/news/292523587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292523587.md)
generator: "portal-rs"
---

# Jefferies favors low-volatility, high-yield U.S. stocks as AI volatility spikes

According to CNBC, Jefferies analyst Desh Peramunetilleke said volatility in the AI theme has jumped on concerns about hyperscaler ROI versus potential overcapacity, elevated expectations, large fund-raisings and extreme positioning, and he expects those factors could unwind AI-led momentum. He said he prefers low-volatility stocks with high dividends or free-cash-flow yields as a hedge against a sharp correction, screening U.S. companies with market caps above $10 billion in the bottom quintile of volatility, a 12-month forward dividend yield above 3% or a free cash flow yield above 3% over the last 12 months, and positive or flat 2026 estimated EPS revisions over the last three months. Names highlighted included Procter & Gamble with a 3% 12-month forward dividend yield and fiscal fourth-quarter earnings due July 29; Pfizer with a 6.9% forward dividend yield and results expected Aug. 4, after the FDA approved its Padcev and Keytruda combination for muscle-invasive bladder cancer and after an experimental lung cancer drug missed a late-stage trial endpoint; Simon Property Group with a 4.30% forward dividend yield, up 18% in 2026, after raising full-year guidance and its quarterly dividend; and KeyCorp with a 3.8% forward dividend yield, up about 12% year to date, with second-quarter earnings due July 21.

### Related Stocks

- [PG.US](https://longbridge.com/en/quote/PG.US.md)
- [SPG.US](https://longbridge.com/en/quote/SPG.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [KEY.US](https://longbridge.com/en/quote/KEY.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [SPG-J.US](https://longbridge.com/en/quote/SPG-J.US.md)
- [SPGSW.US](https://longbridge.com/en/quote/SPGSW.US.md)
- [KEY-K.US](https://longbridge.com/en/quote/KEY-K.US.md)
- [KEY-L.US](https://longbridge.com/en/quote/KEY-L.US.md)
- [KEY-J.US](https://longbridge.com/en/quote/KEY-J.US.md)
- [KEY-I.US](https://longbridge.com/en/quote/KEY-I.US.md)

## Related News & Research

- [What Does Procter & Gamble (PG) Have Riding On Its New Product Push?](https://longbridge.com/en/news/298812424.md)
- [Procter & Gamble Company (The) $PG Shares Sold by Corient Private Wealth LP](https://longbridge.com/en/news/298699218.md)
- [Simon Property Group sells $800M of senior notes](https://longbridge.com/en/news/298508778.md)
- [TwoStep Therapeutics raises $62.5 million in Series A led by Insight Partners, Medical Excellence Capital](https://longbridge.com/en/news/298489357.md)
- [Novartis India acquires Pfizer brands for $132m](https://longbridge.com/en/news/298290980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**